“Real‐world” eligibility for aducanumab depends on clinical setting and patients' journey-Reference-Cited by-同舟云学术

“Real‐world” eligibility for aducanumab depends on clinical setting and patients' journey

Published:2021-11-09 Issue:2 Volume:70 Page:626-628
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J American Geriatrics Society

Author:

Padovani Alessandro¹²^ORCID,Caratozzolo Salvatore²,Rozzini Luca¹²,Pilotto Andrea¹²^ORCID,Benussi Alberto¹²,Tedeschi Gioacchino³

Affiliation:

1. Neurology Unit, Department of Clinical and Experimental Sciences University of Brescia Brescia Italy

2. Neurology Unit, Department of Neurological and Vision Sciences ASST Spedali Civili Brescia Italy

3. Neurology Unit, Department of Advanced Medical and Surgical Sciences University of Campania "Luigi Vanvitelli" Naples Italy

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.17530

Reference12 articles.

1. Alzheimer's disease: a time for cautious optimism;The Lancet Neurology;Lancet Neurol,2015

2. Assessing the preparedness of the health care system infrastructure in six European countries for an Alzheimer's treatment;Hlavka JP;Rand Health Q,2019

3. The Italian Dementia National Plan;Di Fiandra T;Ann Ist Super Sanita,2015

4. Italian consensus recommendations for a biomarker‐based aetiological diagnosis in mild cognitive impairment patients

5. How many patients are eligible for disease‐modifying treatment in Alzheimer's disease? A French national observational study over 5 years;Epelbaum S;BMJ Open,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging;Neurology;2023-11-07

2. Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design;Alzheimer's Research & Therapy;2023-09-15

3. Impact of seed amplification assay and surface-enhanced Raman spectroscopy combined approach on the clinical diagnosis of Alzheimer’s disease;Translational Neurodegeneration;2023-07-12

4. Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients;JAMA Neurology;2023-06-01

5. Understanding Barriers Along the Patient Journey in Alzheimer’s Disease Using Social Media Data;Neurology and Therapy;2023-04-15